6/12
10:24 am
oncy
Pancreatic Cancer on the Rise: How Biotech Firms are Developing Groundbreaking Treatments
Low
Report
Pancreatic Cancer on the Rise: How Biotech Firms are Developing Groundbreaking Treatments
6/12
10:22 am
oncy
Pancreatic Cancer on the Rise: How Biotech Firms are Developing Groundbreaking Treatments
Low
Report
Pancreatic Cancer on the Rise: How Biotech Firms are Developing Groundbreaking Treatments
6/3
09:20 am
oncy
Biotech Advances in 2024: Innovative Treatments Aim to Boost Pancreatic Cancer Survival Rates
Low
Report
Biotech Advances in 2024: Innovative Treatments Aim to Boost Pancreatic Cancer Survival Rates
6/3
09:17 am
oncy
Biotech Advances in 2024: Innovative Treatments Aim to Boost Pancreatic Cancer Survival Rates
Medium
Report
Biotech Advances in 2024: Innovative Treatments Aim to Boost Pancreatic Cancer Survival Rates
5/24
12:20 pm
oncy
Emerging Trends in Oncology: ASCO 2024 Highlights Next-Gen Antibody-Drug Conjugates and More
Low
Report
Emerging Trends in Oncology: ASCO 2024 Highlights Next-Gen Antibody-Drug Conjugates and More
5/24
12:16 pm
oncy
Emerging Trends in Oncology: ASCO 2024 Highlights Next-Gen Antibody-Drug Conjugates and More
Low
Report
Emerging Trends in Oncology: ASCO 2024 Highlights Next-Gen Antibody-Drug Conjugates and More
5/24
08:45 am
oncy
Biotechs Zero in on New Pancreatic Therapies as Global Pancreatic Cancer Market Expected Reach to $7.4 Billion By 2032
Low
Report
Biotechs Zero in on New Pancreatic Therapies as Global Pancreatic Cancer Market Expected Reach to $7.4 Billion By 2032
5/24
07:12 am
oncy
Oncolytics Biotech® ASCO Abstracts Highlight Pelareorep's Potential in Pancreatic Cancer and Immunotherapeutic Mechanism of Action [Yahoo! Finance]
Low
Report
Oncolytics Biotech® ASCO Abstracts Highlight Pelareorep's Potential in Pancreatic Cancer and Immunotherapeutic Mechanism of Action [Yahoo! Finance]
5/24
07:00 am
oncy
Oncolytics Biotech® ASCO Abstracts Highlight Pelareorep's Potential in Pancreatic Cancer and Immunotherapeutic Mechanism of Action
Neutral
Report
Oncolytics Biotech® ASCO Abstracts Highlight Pelareorep's Potential in Pancreatic Cancer and Immunotherapeutic Mechanism of Action
5/24
07:00 am
oncy
Oncolytics Biotech® ASCO Abstracts Highlight Pelareorep's Potential in Pancreatic Cancer and Immunotherapeutic Mechanism of Action
Neutral
Report
Oncolytics Biotech® ASCO Abstracts Highlight Pelareorep's Potential in Pancreatic Cancer and Immunotherapeutic Mechanism of Action
5/23
11:53 am
oncy
Pancreatic Cancer Battle Intensifies: Biotech Innovations Aim to Boost Survival Rates
Low
Report
Pancreatic Cancer Battle Intensifies: Biotech Innovations Aim to Boost Survival Rates
5/23
11:51 am
oncy
Pancreatic Cancer Battle Intensifies: Biotech Innovations Aim to Boost Survival Rates
Low
Report
Pancreatic Cancer Battle Intensifies: Biotech Innovations Aim to Boost Survival Rates
5/17
12:55 pm
oncy
Early Detection Breakthrough: Biotech Companies Lead the Way in Pancreatic Cancer Treatment
Low
Report
Early Detection Breakthrough: Biotech Companies Lead the Way in Pancreatic Cancer Treatment
5/17
12:50 pm
oncy
Early Detection Breakthrough: Biotech Companies Lead the Way in Pancreatic Cancer Treatment
Low
Report
Early Detection Breakthrough: Biotech Companies Lead the Way in Pancreatic Cancer Treatment
5/16
07:06 am
oncy
Oncolytics Biotech® Announces Voting Results from the Annual General Meeting of Shareholders [Yahoo! Finance]
Medium
Report
Oncolytics Biotech® Announces Voting Results from the Annual General Meeting of Shareholders [Yahoo! Finance]
5/16
07:00 am
oncy
Oncolytics Biotech® Announces Voting Results from the Annual General Meeting of Shareholders
Medium
Report
Oncolytics Biotech® Announces Voting Results from the Annual General Meeting of Shareholders
5/16
07:00 am
oncy
Oncolytics Biotech® Announces Voting Results from the Annual General Meeting of Shareholders
Medium
Report
Oncolytics Biotech® Announces Voting Results from the Annual General Meeting of Shareholders
5/15
11:17 am
oncy
Biotech Companies Making Strides in Pancreatic Cancer Treatment and Early Detection
Low
Report
Biotech Companies Making Strides in Pancreatic Cancer Treatment and Early Detection
5/15
11:14 am
oncy
Biotech Companies Making Strides in Pancreatic Cancer Treatment and Early Detection
Low
Report
Biotech Companies Making Strides in Pancreatic Cancer Treatment and Early Detection
5/15
07:12 am
oncy
Oncolytics Biotech® Announces Preliminary Collaboration with GCAR for Inclusion of Pelareorep in Anticipated Pancreatic Cancer Trial [Yahoo! Finance]
Medium
Report
Oncolytics Biotech® Announces Preliminary Collaboration with GCAR for Inclusion of Pelareorep in Anticipated Pancreatic Cancer Trial [Yahoo! Finance]
5/15
07:00 am
oncy
Oncolytics Biotech® Announces Preliminary Collaboration with GCAR for Inclusion of Pelareorep in Anticipated Pancreatic Cancer Trial
Medium
Report
Oncolytics Biotech® Announces Preliminary Collaboration with GCAR for Inclusion of Pelareorep in Anticipated Pancreatic Cancer Trial
5/15
07:00 am
oncy
Oncolytics Biotech® Announces Preliminary Collaboration with GCAR for Inclusion of Pelareorep in Anticipated Pancreatic Cancer Trial
Medium
Report
Oncolytics Biotech® Announces Preliminary Collaboration with GCAR for Inclusion of Pelareorep in Anticipated Pancreatic Cancer Trial
5/14
08:06 am
oncy
Oncolytics Biotech Inc. (NASDAQ: ONCY) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $5.00 price target on the stock.
Medium
Report
Oncolytics Biotech Inc. (NASDAQ: ONCY) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $5.00 price target on the stock.
5/10
04:46 pm
oncy
Oncolytics Biotech Inc. (NASDAQ:ONCY) Q1 2024 Earnings Call Transcript [Yahoo! Finance]
Low
Report
Oncolytics Biotech Inc. (NASDAQ:ONCY) Q1 2024 Earnings Call Transcript [Yahoo! Finance]
5/9
04:12 pm
oncy
Oncolytics Biotech® Reports First Quarter 2024 Financial Results and Operational Highlights [Yahoo! Finance]
Low
Report
Oncolytics Biotech® Reports First Quarter 2024 Financial Results and Operational Highlights [Yahoo! Finance]